Trials evaluating nicorandil renoprotection against contrast-induced nephropathy after coronary angiography or percutaneous coronary intervention: a systematic review and meta-analysis
This study demonstrated the renoprotective effects of nicorandil in preventing CIN in patients undergoing coronary angioplasty, and this relationship was also evident from the double-dose response. Further larger size randomised controlled trials are recommended to assess the efficacy of nicorandil in preventing CIN in patients undergoing coronary angioplasty.
Authors
- Nestor Lemos Ferreira
- Krishnaraj Sinhji Rathod (ORCID: https://orcid.org/0000-0003-4268-5055)
- Mohammadrafi Damirchi (ORCID: https://orcid.org/0000-0001-8889-5109)
- Sujit S. Nair (ORCID: https://orcid.org/0000-0002-3039-523X)
- Mohamed Shehab (ORCID: https://orcid.org/0000-0002-7012-1890)
- Daniel A. Jones (ORCID: https://orcid.org/0000-0003-1441-0417)
- Zahid Khan (ORCID: https://orcid.org/0000-0002-0710-2419)
- Débora Regina de Aguiar (ORCID: https://orcid.org/0000-0003-2465-6306)
- Abiodun Bamidele Adelowo (ORCID: https://orcid.org/0000-0003-0064-2209)
Institutions
- Amrita Institute of Medical Sciences and Research Centre (IN)
- Niger Delta University (NG)
- Queen Mary University of London (GB)
- Golestan University (IR)
- British Heart Foundation (GB)
- Golestan University of Medical Sciences (IR)
- Hospital Sírio-Libanês (BR)
- Menoufia University (EG)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- The Egyptian Heart Journal
- Published
- 2025-11-16
- DOI
- https://doi.org/10.1186/s43044-025-00705-4
- Primary Topic
- Acute Kidney Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00